Sun, January 19, 2025
Sat, January 18, 2025
Fri, January 17, 2025
Thu, January 16, 2025
Wed, January 15, 2025

Ozempic, Wegovy and other new drugs are selected for Medicare's price negotiations


  Copy link into your clipboard //politics-government.news-articles.net/content/ .. -selected-for-medicare-s-price-negotiations.html
  Print publication without navigation Published in Politics and Government on by MSN
          🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source


  Ozempic, Wegovy and other new drugs are selected for Medicare's price negotiations - The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare's list

The article from MSN discusses how the Biden administration has selected Ozempic, Wegovy, and other new drugs for Medicare's price negotiations as part of the Inflation Reduction Act. This initiative aims to lower the cost of prescription drugs for Medicare beneficiaries. The drugs chosen for negotiation include treatments for diabetes, obesity, and heart failure, which are significant due to their high costs and the large number of patients they serve. The negotiations are intended to make these medications more affordable, potentially saving money for both the government and taxpayers while improving access to essential treatments. The process involves pharmaceutical companies negotiating with Medicare to set a maximum fair price, which could lead to reduced out-of-pocket expenses for millions of seniors. However, the article also notes that this move has sparked controversy, with pharmaceutical companies and some lawmakers arguing that it could stifle innovation in drug development.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/politics/government/ozempic-wegovy-and-other-new-drugs-are-selected-for-medicare-s-price-negotiations/ar-AA1xnAv3 ]

Publication Contributing Sources